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Abstract  
Introduction This study aims to determine serum lactate dehydrogenase activity and its correlation 
with carbohydrate intake in advanced lung cancer patients at Dharmais National Cancer Hospital 
Jakarta. Anaerobic glycolysis is increased in cancer cells, termed the Warburg effect. This results in 
lactate as an end product, catalysed by LDH enzyme. Activities of lactate in cancer influence tumor 
growth initiation, survival, proliferation, angiogenesis and metastasis. Serum LDH activity can be 
used as a diagnostic, prognostic, and predictive marker for tumor sensitivity and resistance to 
therapy.  
Methods A total of 56 advanced lung cancer patients from Dharmais National Cancer Hospital 
Jakarta were included in this cross sectional study. Subjects were recruited by consecutive sampling. 
Food intake of total carbohydrate was obtained using 24 hours food recall method. The activity of 
serum LDH (IU/L) was measured by using enzymatic spectrophotometry method in automated 
analyzer.  
Results The mean of age subjects was 56.98 ± 10.36 years old and 55.4% were male. Carbohydrate 
intake based on 24 hours food recall was 57.64 ± 10,85%. The median of LDH activity was 54.5 (164–
6539) IU/L, with 60.7% increased. This study showed medium negative significant correlation (p = 
0.017, r = -0.317) between total carbohydrate intake per day in grams with LDH serum activity. 
Conclusion If carbohydrate source is reduced, the LDH enzyme will increase to keep the glycolysis 
process going. The results of this study showed adequate carbohydrate is needed in patients with 
cancer. 
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Introduction 
 
Cancer is one of the major causes of morbidity and 
mortality in the world. According to the Global 
Burden of Cancer (GLOBOCAN) data in 2012,  
 
lung cancer has the highest incidence rate and is the 
leading cause of death in men.1 Lung cancer is one 
of the three most common cancer types in Dharmais 
Cancer Hospital during year 2010–2013.2 Lung 
cancer patients have poor prognosis and 85% of 
patients are diagnosed at an advanced stage.3 
 There is an altered energy metabolism and 
mitochondrial respiration in cancer cells. 
Carbohydrate metabolism changes in cancer cells is 
an increased anaerobic glycolysis rate which 
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converts pyruvate to lactate even in oxygenated 
conditions, known as the Warburg effect. 
Conversion of pyruvate to lactate in cancer cells is 
catalyzed by lactate dehydrogenase (LDH) enzyme.4 
This enzyme is scattered in various tissues and its 
level in the blood increases in several diseases 
including malignancy.5 The roles of LDH in cancer 
cells including the initiation of tumor growth, 
maintaining cancer cell survival, progression, and 
metastasis. LDH activities can become a marker to 
identify different types of malignancy and as a 
prognostic marker to determine the survival of 
cancer patients.6 
 The aim of this study was to determine 
serum lactate dehydrogenase (LDH) activity and its 
correlation with carbohydrate intake in advanced 
lung cancer patients. Previous research by Amanda 
et al.7 in 49 lung cancer patients at Dharmais Cancer 
Hospital reported 53.1% of subjects showed total 
energy intake below ESPEN recommendation, 
75.5% of subjects were in sufficient carbohydrate 
intake with 30.6% subjects were in sufficient simple 
carbohydrate intake. Yoshimura et al.8 research in 
healthy subjects obtained a negative correlation 
between the percentage of LDH isoenzymes with 
protein and fat intake. Research by Klement and 
Swenney in six cancer patients given ketogenic diet 
(carbohydrate <50 grams per day), get the result of 
tumor regression and tumor growth deceleration. 
Thus, modification of carbohydrate intake may 
affect tumor development associated with patient 
prognosis and survival.9 
 Research about the effect of nutritional intake 
with the development of cancer cells is still limited. 
There has been no research on the correlation 
between carbohydrate intake to LDH activity. It is 
expected to know the correlation between serum 
LDH activity with carbohydrate intake in lung 
cancer patients to support nutritional management in 
cancer patients from this research. 
 
Methods 
 
Subjects and study design 
A cross sectional study was conducted to patients 
with advanced lung cancer at Dharmais National 
Center Hospital Jakarta from March 2018 to May 
2018 using consecutive sampling method. The 
minimal estimation of minimum sample size was 
calculated using the formula for correlation study by 
taking α=0.05, β=0.20, and r=0.4 with 20% addition, 
thus a total number 57 subjects were required. The 
study was approved by the committee of the Medical 
Research Ethics of the Dharmais Cancer Hospital. 
All patients enrollments were voluntary and with 
informed consent. 
Inclusion criteria were men and women age 
18 years old, diagnosed with primary lung cancer, 
any stadium, and currently not receiving any 
therapy. Subject who had diabetes mellitus, end 
stage chronic kidney disease, chronic liver disease, 
cardiovascular disease, tuberculosis, pregnant, any 
bacterial infection, and trauma were excluded from 
this study. 
 
Data collection 
Interviews were conducted to determine 
characteristic of the subject. Histopathology and 
cancer stadium data were determined from the 
medical record. Food intake of total energy and total 
carbohydrate were obtained using 24 hours food 
recall method. Anthropometric measurements 
including weight, height and body mass index 
(BMI). Weight was measured using SECA® 
electrodigital scale, height with Microtoise Stature 
Meter, and BMI was categorized into five groups 
according to the Asian Pacific criteria of BMI. 
Serum activity of LDH (IU/L) were measured with 
an enzymatic spectrophotometry method in 
automated analyzer (Roche Cobas 6000 C 501).10 A 
high LDH value was defined as ≥480 IU/L.11 
 
Statistical analysis 
Data were analyzed using the Statistical Package for 
the Social Sciences (SPSS) version 20 for Windows. 
The normality of data distribution was analyzed 
using Kolmogorov-Smirnov. If p<0.05 data were 
normal distributed and were presented in mean ± 
standard deviation. If it is not normal, data are 
presented in median and minimum-maximum range 
of values. The correlation of carbohydrate intake 
with LDH activity serum were analyzed by 
Spearman Rank correlation test. 
 
Results 
 
Subject characteristic 
 
Based on the inclusion and exclusion criteria, 60 
subjects were willing to take part in this study and 
signed an informed consent. In blood sampling 
collection, there were 4 subjects who refused. 
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Total subjects who followed this study and whose 
data could be analyzed was 56 subjects. From this 
study, the average age of subjects was 56.98 ± 10.36 
years. A total of 55.4% subjects were male. From the 
pathology results, it was revealed that all subjects 
had non-small cell carcinoma types: 78.6% were 
adenocarcinoma and 21.4% were squamous 
carcinoma. Based on cancer stage, 96.4% of subjects 
were in stage IV and 3.6% were in stage III-B. The 
average value of subjects’ BMI was 20.59 ± 3.86 
kg/m2 and 39.3% were in normal range of BMI. 
These results are shown in Table 1. 
 
 
 
 
Characteristic distribution based on energy and 
carbohydrate intake 
The median value of total energy intake measured 
by 24 hours food recall method was 1459.25 (425.9–
2205.9) kcal (Table 2). From the analysis, 64.3% of 
subjects had low level of energy intake. 
Carbohydrate intake to total energy was in a good 
amount (64.3%). 
 
Characteristics distribution based on LDH 
serum activity  
The median value of LDH serum activity was 541.5 
(164–6539) IU/L. There were 34 subjects (63%) had 
LDH serum value above 480 IU/L. The 
Table 1. Characteristic of subjects (n=56) 
 
Characteristic Results 
Age, (year) 56.98 ± 10.36* 
Sex, n (%) 
   Men  
   Women   
 
31 (55.4) 
25 (44.6) 
Education, n (%) 
   Low 
   Middle 
   High 
 
17 (30.4) 
28 (50) 
11 (19.6) 
Histopathology, n (%) 
   Non small cell lung carcinoma 
      Adenocarcinoma 
      Squamous cell carcinoma 
      Large cell carcinoma 
  Small cell lung carcinoma 
 
56 (100) 
44 (78.6) 
12 (21.4) 
0 (0) 
0 (0) 
Stage, n (%) 
   Stage III-B 
   Stage IV 
 
2 (3.6) 
54 (96.4) 
Anthropometric 
   Weight (kg) 
   Height (cm) 
   Body mass index (kg/m2) 
 
50 (35–78) 
160.06 ± 7.54 
20.59 ± 3.86 
Body mass index classification, n (%) 
   Underweight 
   Normal 
   Overweight 
   Obese 1 
   Obese 2 
 
18 (32.1) 
22 (39.3) 
9 (16.1) 
7 (12.5) 
0 (0) 
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characteristic of subjects based on their LDH serum 
activity is shown in Table 3. 
 
The correlation between carbohydrate intake 
and LDH serum activity 
This research revealed a medium negative 
correlation (p = 0.017, r = -0.317) between LDH 
serum activity and total carbohydrate intake per day 
(in grams) based on 24 hours food recall (Table 4). 
No significant correlation was found between LDH 
serum activity and carbohydrate intake of total 
energy. 
Discussion 
 
A total of 55.4% of the subjects in this study were 
male. The results of this study are consistent with 
GLOBOCAN data in 2012 that lung cancer was the 
leading cause of death with the highest incidence 
rate in male.1 Data from WHO also mentioned that 
lung cancer is the most common type of cancer 
affecting males in Indonesia.12 
This study shows the average age of the 
subjects was 56.98 ± 10.36 years old. The data is 
consistent with the Riskesdas data in 2013.13 
Previous research conducted by Anwar et al.13 in 
lung cancer patients in 2010 – 2011 revealed similar 
results. Based on the research by Amanda et al.7 in 
lung cancer patients stage IIIB and IV in Dharmais 
Cancer Hospital in 2107, the average age of subjects 
was 55.83 ± 12.62 years with the majority in the 
range of 45–65 years, which is also similar to the 
findings of this research.  
Classification of lung cancer can be 
distinguished into non-small cell lung cancer 
(NSCLC) and small cell lung cancer (SCLC), with 
prevalence of 80% for NSCLC.3 All subjects in this 
research had NSCLC type.  
Table 2. Characteristics distribution based on energy and carbohydrate intake (n=56) 
 Results 
Variable 24 hours food recall 
Total energy intake per day  (kcal) 
Low, n (%) 
Average, n (%) 
 
1459.25 (425.9–2205.9) 
36 (64.3) 
20 (35.7) 
 
Total carbohydrate intake per day (g) 
Total carbohydrate of total energy, (%) 
   Low, n (%) 
   Average, n (%) 
   High, n (%) 
202.54 ± 91.53 
57.64 ± 10.85 
7 (12.5) 
36 (64.3) 
13 (23.2) 
 
Table 3. Characteristics distribution based on LDH serum activity (n=56) 
Variable Results 
LDH serum activity (IU/L) 
   Normal, n (%) 
   High, n (%) 
541.5 (164–6539)* 
22 (39.3) 
34 (60.7) 
Stage III-B 
    Normal, n (%) 
    High, n (%) 
 
2 (100) 
0 
Stage IV 
    Normal, n (%) 
    High, n (%) 
 
20 (37) 
34 (63) 
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There were 78.6% subjects who had 
adenocarcinoma type. Around 96.4% subjects were 
in the stage IV. The result is similar with the research 
conducted by Anwar et al.13 in Persahabatan 
hospital. Research by Siregar et al.14 which was 
related to lung cancer patients showed 66.6% of the 
subjects had adenocarcinoma, while the rest had 
small cell carcinoma.  
Around 39.3% subjects had normal BMI. 
Previous research in 2017 at the Dharmais Cancer 
Hospital showed similar results: 36.7% and 22.5% 
subjects had normal and low BMI, respectively.7 
Total energy intake based on 24 hours food recall 
method showed median value of 1425.25 (425.9-
2205.9) kcal with as much as 64.3% subjects had 
low energy intake. Disease and external factors can 
affect food intake and decreased appetite in cancer 
patients. Substrates released by cancer cells such as 
pro-inflammatory cytokines and lactate, metabolic 
changes, neuro-hormonal changes, cancer types, 
cancer sites, and cancer pain can affect appetite and 
food intake.13 External factors that can affect food 
intake and appetite including age, psychosocial, 
economic, and sociocultural factors.14 Research by 
Solheim et al.15 revealed that food intake will 
decrease along with the increase of age. Family 
support on assisting patients during treatment as 
well as motivation from family in nutritional support 
have impact on appetite and food intake.16 Dharmais 
Cancer Hospital is a national referral hospital thus 
the patients come from diverse sociocultural 
backgrounds. This will affect eating habit and 
appetite of the patient. Type of food, cooking 
method, and taste differ from patient’s eating habit 
can affect appetite and food intake. 
Based on 24 hours food recall, total 
carbohydrate intake on energy requirement was 
57.64 ± 10.85%, with most subjects having 
sufficient total carbohydrate intake. Carbohydrates 
are the main source of energy for the body with a 
recommended daily intake of 45-65% of total 
energy.17 Research by Caesandri et al.16 in cancer 
patients showed 80% of subjects consumed 
carbohydrates as the main food source.  
In this study, 63% of patients had LDH 
activity >480 IU / L. Research by Lee et al.18 in 
NSCLC stage IV patients before therapy revealed 
similar result. High LDH activity correlates to organ 
metastatic such as bones, other lung parts, and 
abdomen. Increased LDH activity in cancer cells 
correlates with inflammation and tumor necrosis 
which describe the activity of cancer cells. Various 
comorbid diseases such as acute heart failure, acute 
coronary syndrome, severe liver dysfunction, end-
stage renal disease, and hemolysis can affect the 
increase of LDH activity.19 Study by Wulaningsih et 
al.20 revealed there were an increased LDH activity 
in patients with blood, colorectal, and lung cancer. It 
was shown that LDH activity was associated with 
cancer prognosis. Proliferation of cancer cells 
requires a lot of energy resulting in increased 
activity of glycolysis. Higher glycolysis results in 
the increased LDH activity to convert pyruvate into 
lactate which is the main ATP component in cancer 
cells. Increased LDH activity reflects increased 
lactate in cancer cells. Lactate will come out from 
cancer cells and affect pathways which cause 
increased angiogenesis, tumor migration and 
metastasis, increased resistance to therapy, and 
decreased immunity.21  
This study found 65.4% of stage IV lung 
cancer subjects had high LDH values. Stage IV of 
lung cancer illustrates the presence of distant 
metastases, either to the contralateral lung, nodules 
in the pleura, malignant pleural effusions, 
pericardial effusion (stage 4A), or metastases to 
other organs such as liver, brain, bones or suprarenal 
(stage 4B).2 Research conducted by Hermes et al.19 
in SCLC patients showed LDH activity was found 
Table 4. The correlation between carbohydrate intake with LDH serum activity (n=56) 
Carbohydrate intake LDH serum  
       r    P 
Carbohydrate intake per day (g) 
24 hours food recall 
 
- 0.317┼ 
 
0.017 
 
Carbohydrate intake of total energy (%) 
24 hours food recall 
 
- 0.136┼ 
 
0.316 
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to increase consistently with the number of organs 
affected. 
Medium negative correlation (r = -0.317, p = 
0.017) was found between total carbohydrate intake, 
based on 24 hours food recall method, with serum 
LDH activity. Intake analysis using the 24 hours 
food recall method is widely used in surveillance 
studies to determine food intake in a population.22 
Food data from 24 hours recall describes short-term 
intake. LDH activity increases to supply high 
glucose needs by catalyzing the change of lactate to 
pyruvate as gluconeogenesis component. In 
addition, to supply the need for glucose as the basic 
ingredient of glycolysis, the intake of external 
carbohydrates is needed as the main source of 
glucose. This amount of intake can be analyzed by 
using 24 hour food recall.  
The Warburg effect, which is described as 
the tendency of cells to get energy in the form of 
ATP through anaerobic glycolysis process even 
though in a state of sufficient oxygen, occurs in 
cancer cells. LDH is an enzyme which converts 
pyruvate into lactate in the anaerobic glycolysis 
process.23 In cancer cells, most of the lactate is 
exported out of cells by increasing the expression of 
monocarboxylate transporters (MCT), which acts as 
facilitator to transport lactate out of the cell. 
Continuous formation of lactate in order to obtain 
ATP occurs due to oncogenes and mutations in 
tumor suppressors in cancer cells. Furthermore, in 
cancer cells, there is an increased of HIF-Iα 
transcription factor and c-Myc oncogene, also 
repressed p53 expression. These increase GLUT 
(glucose transporter) expression and translocation 
which then results in increased lactate formation. 
Expression and activity of glycolytic enzymes, 
especially LDH isoenzymes LDHA, also escalated 
due to HIF-Iα, c-MYC, and down regulation of p53. 
Increased isoenzyme LDHA will convert pyruvate 
to lactate. Moreover, mitochondrial dysfunction as 
well as upregulation of MCT1 and MCT4 as lactate 
transporters also increase lactate production in 
cancer cells.24  
Increased glycolysis rate to obtain ATP due 
to oncogenes and mutations of tumor suppressors in 
cancer cells also causes NAD+ depletion. To 
achieve balance between NADH and NAD+, in 
order to maintain the glycolysis process, pyruvate 
will be further converted to lactate by the LDH 
enzyme.24 If the glucose obtained from carbohydrate 
source is reduced the LDH enzyme will increase in 
order for the glycolysis process to obtain ATP and 
maintain the redox balance by converting pyruvate 
to lactate. High rates of glycolysis lead to decreased 
glycogen reserves in the liver resulting in increased 
proteolysis for gluconeogenesis. Chronic proteolysis 
is one of cancer cachexia pathophysiology of.25 If 
too much glucose is given then it will be used by 
cancer cells to process anaerobic glycolysis and 
form ATP by converting pyruvate to lactate.26 This 
is supported by the overexpression of GLUT 1 
transporters in cancer cells as the main transporters 
of glucose.27 The high level of lactate in cells 
stimulates VEGF production which has a role in cell 
migration and angiogenesis process. Lactate in 
cancer cells can act as an antioxidant resulting in 
resistance to chemotherapy and radiation.21 
The ESPEN recommendation of total energy 
intake for cancer patients is 25–30 kcal 
/bodyweight/day. Inadequate energy intake can 
cause malnutrition in cancer patients. Adequate 
energy intake does not affect the growth of cancer 
cells. Basal energy requirements in patients with 
lung cancer are higher than other types of cancer.28 
The mechanism of high basal energy demand in lung 
cancer is unclear. It may be related to systemic 
inflammation.29   
In conclusion, if carbohydrate source is 
reduced, the LDH enzyme will increase to sustain 
the glycolysis process. The results of this study 
showed adequate carbohydrate is needed to improve 
the quality and life expectancy in lung cancer 
patients. 
This study was the first cross sectional study 
aiming to find the correlation between carbohydrate 
intake with LDH activity as one of the determinants 
of prognosis in lung cancer patients. The advantage 
of this study was using serum LDH activity 
biomarkers as one of the prognostic markers in lung 
cancer patients. In addition, calibrated 
anthropometry tools were used to measure height 
and weight. The collection of blood specimens and 
the analysis of laboratory results were performed by 
well-trained laboratory personnel and analysts. 
Limitation in this study was the utilization of 
24 hours food recall method to determine the 
carbohydrate intake. This method relies on the 
memory and assumptions of the intake portions by 
each subject. However, this had been anticipated, 
thus we used trained personnel and food models to 
help the subject to remember and estimate the 
number of foods.  
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Further research may be needed using LDH-
A isoenzymes, which is a more specific LDH 
markers, to assess carbohydrate metabolism in lung 
cancer patients. 
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